MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells
Yi-Yen Lee,1,2,* Aliaksandr A Yarmishyn,3,4,* Mong-Lien Wang,3,4 Hsiao-Yun Chen,4,5 Shih-Hwa Chiou,3–5 Yi-Ping Yang,4,5 Chun-Fu Lin,1,2 Pin-I Huang,2,6 Yi-Wei Chen,2,6 Hsin-I Ma,7 Ming-Teh Chen1,2 1Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, 2Facul...
Main Authors: | Lee YY, Yarmishyn AA, Wang ML, Chen HY, Chiou S, Yang YP, Lin C, Huang PI, Chen YW, Ma HI, Chen M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/microrna-142-3p-is-involved-in-regulation-of-mgmt-expression-in-gliobl-peer-reviewed-article-CMAR |
Similar Items
-
Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
by: Yue Wu, et al.
Published: (2022-12-01) -
Prognostic genetic markers in malignant gliomas
by: Ralf Ketter, et al.
Published: (2010-12-01) -
Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo
by: Thomas C. Chen, et al.
Published: (2018-09-01) -
Quantitative Analysis of the <i>MGMT</i> Methylation Status of Glioblastomas in Light of the 2021 WHO Classification
by: Levin Häni, et al.
Published: (2022-06-01) -
Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status
by: Qiong Wu, et al.
Published: (2023-10-01)